PATENT CLAIM ANALYSIS

Application Number: 16307450
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-06
Patent Classification: ["530", "322000"]

Abstract:
The invention provides Dsg2-derived peptides for inhibiting EMT and/or vasculogenic mimicry and treating and/or preventing angiogenesis-related diseases. Also provided are pharmaceutical compositions comprising the peptide of the invention and methods of using the peptide of the invention in inhibiting EMT and/or vasculogenic mimicry, and treating and/or preventing angiogenesis-related diseases.

Claim (Index 30):
The use of  claim 22 , wherein the angiogenic dependent or angiogenic associated disease is ocular neovascular disease or macular degeneration.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 98.0
- Lexical Diversity: 1.73333
- Patent Class: 530.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13992998', '14896521', '15395648', '14745562', '13516511']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6599051939451828
- 35 USC 102 Novelty (BERT): 0.5196486913919321
- Combined Prediction Score: 0.6458795436898577
- Mean Citation Score: 266.771986
- Max Citation Score: 268.7109
- Similarity Product: 167.24375438797472

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test